Viewing Study NCT00004857


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2025-12-28 @ 4:55 AM
Study NCT ID: NCT00004857
Status: COMPLETED
Last Update Posted: 2016-07-06
First Post: 2000-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module